Received Jun 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
Mine started behind my eye, my vision was affected; Mine started behind my eye, my vision was affected,; This serious case was reported by a consumer via interactive digital media and described the occurrence of ophthalmic herpes zoster in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced ophthalmic herpes zoster (Verbatim: Mine started behind my eye, my vision was affected) (serious criteria hospitalization and GSK medically significant) and facial herpes zoster (Verbatim: Mine started behind my eye, my vision was affected,) (serious criteria hospitalization). The patient was treated with gabapentin. The outcome of the ophthalmic herpes zoster and facial herpes zoster were not resolved. It was unknown if the reporter considered the ophthalmic herpes zoster and facial herpes zoster to be related to Shingles vaccine. The company considered the ophthalmic herpes zoster and facial herpes zoster to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date : 27-MAY-2025 This case was reported by a patient via interactive digital media. The patient was on year four with shingles. The patient started behind his/her eye, his/her vision was affected, side of his/her nose up to his/her scalp back to his/her forehead. The patient was in the hospital for two days for fear of sepsis. The patient was taken Gabepentin and a cream for forehead. The patient got the shingles shot but did not go back for the second shot. The physician said after this long it probably would not go away.; Sender's Comments: Ophthalmic herpes zoster and Herpes zoster are unlisted events which are considered unrelated to GSK vaccine Shingles vaccine.